MERIT MEDICAL SYSTEMS INC

For the period ended Jun 30, 2024. Filed Aug 1, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2024 · Filed Aug 1, 2024

MMSI$88.42+1.4%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets

(In thousands)


· June 30, · December 31,
ASSETS · 2024 · 2023
	(unaudited)
Current assets: · ·
Cash and cash equivalents	$636,658	$587,036
Trade receivables — net of allowance for credit losses — 2024 — $9,276 and 2023 — $9,023	182,415	177,885
Other receivables	10,612	10,517
Inventories	298,224	303,871
Prepaid expenses and other current assets	26,179	24,286
Prepaid income taxes	4,123	4,016
Income tax refund receivables	4,335	859
Total current assets	1,162,546	1,108,470

Property and equipment:
Land and land improvements	25,952	26,017
Buildings	191,030	191,491
Manufacturing equipment	330,290	316,930
Furniture and fixtures	64,755	63,044
Leasehold improvements	58,595	53,638
Construction-in-progress	61,060	61,439
Total property and equipment	731,682	712,559
Less accumulated depreciation	(345,743)	(329,036)
Property and equipment — net	385,939	383,523

Other assets:
Intangible assets:
Developed technology — net of accumulated amortization — 2024 — $346,763 and 2023 — $321,488	264,195	283,999
Other — net of accumulated amortization — 2024 — $80,628 and 2023 — $76,887	39,227	41,884
Goodwill	381,433	382,240
Deferred income tax assets	7,013	7,288
Right-of-use operating lease assets	69,903	63,047
Other assets	61,583	54,793
Total other assets	823,354	833,251

Total assets	$2,371,839	$2,325,244


See condensed notes to consolidated financial statements.	(continued)

CONSOLIDATED BALANCE SHEETS

(In thousands)


· June 30, · December 31,
LIABILITIES AND STOCKHOLDERS’ EQUITY · 2024 · 2023
	(unaudited)
Current liabilities: · · ·
Trade payables	$55,573	$65,944
Accrued expenses	117,574	120,447
Short-term operating lease liabilities	11,743	12,087
Income taxes payable	1,325	5,086
Total current liabilities	186,215	203,564

Long-term debt	801,321	823,013
Deferred income tax liabilities	5,510	5,547
Long-term income taxes payable	347	347
Liabilities related to unrecognized tax benefits	1,912	1,912
Deferred compensation payable	18,588	17,167
Deferred credits	1,553	1,605
Long-term operating lease liabilities	58,036	56,259
Other long-term obligations	15,912	13,830
Total liabilities	1,089,394	1,123,244

Commitments and contingencies

Stockholders' equity:
Preferred stock — 5,000 shares authorized; no shares issued as of June 30, 2024 and December 31, 2023	—	—
Common stock, no par value — 100,000 shares authorized; issued and outstanding as of June 30, 2024 - 58,192 and December 31, 2023 - 57,858	658,724	638,150
Retained earnings	639,150	575,184
Accumulated other comprehensive loss	(15,429)	(11,334)
Total stockholders’ equity	1,282,445	1,202,000

Total liabilities and stockholders’ equity	$2,371,839	$2,325,244


See condensed notes to consolidated financial statements.	(concluded)

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.